Join Asgard Therapeutics at the Lund Stem Cell Center 20th Anniversary Conference, taking place from April 17th to 19th, where our team of scientists will be presenting posters that highlight our cutting-edge approach to cancer therapy. bit.ly/43KmZV5 #cancerimmunotherapy #conference

Exciting news! Asgard Therapeutics led by Co-founder and CEO Cristiana Pires, has been selected for the #WomenTechEU grant from the European Innovation Council among 467 women-led #DeepTech companies that applied. Read more: bit.ly/3MQb9m9

We are pleased to invite you to join Asgard Therapeutics at Bio€quity Europe. Our CEO, Cristiana Pires will be delivering a presentation highlighting our remarkable progress in the field of cancer immunotherapy. Don't miss this opportunity to meet us! #BioEquity #cancerimmunotherapy

Attention🔔 We are looking for a post-doctoral researcher to join our team at Lund University to work on developing a small molecule-based #reprogramming approach for advancing cancer #Immunotherapy !🧑‍🔬 To apply and find more details of the project visit: rb.gy/k9p6p

Attention🔔 Our team at Lund University is seeking a post-doctoral researcher to focus on developing a small molecule-based chemical #reprogramming strategy for advancing cancer #immunotherapy! To apply and find more details of the project visit: bit.ly/451ZXZJ

Congrats Rita Alves and Pereira Lab 🎉🍾! A great example of how reprogramming leads us to interrogate and inform biology 🧬 Super cool paper 😊

🌟 Join us for a poster presentation by Xiaoli Huang at SITC 2023. 🕐 Time: 9:00 AM – 8:30 PM   📆 Date: Saturday, November 4   📍 Abstract Number: 1204 Read more in our press release: bit.ly/3Qi00dN #AsgardTherapeutics #Immunotherapy #SITC2023

🚀 Must-Attend Event! 🚀 Join us June 18th at Medicon Village for Lund Immunotalks with experts Johanna Olweus & Inge Marie Svane. Network during the Fika session, sponsored by Miltenyi Biotec. Save the date: June 18th, 9-11! 🌟 #LundImmunotalks #ImmunoOncology #Networking

1/2 Don't miss Filipe Pereira's talk at the International Cancer Immunotherapy Conference #CICON24 cancerimmunotherapyconference.org Session (17:15-18:15)- What’s on the Horizon: New Tools, Technologies, and Approaches in Cancer Immunotherapy.

Tumor cell makeover into APCs. Read our digest here 👉 bit.ly/4gmY7sy  Pereira Lab  Ervin Ascic  Fábio Fiúza Rosa Asgard Therapeutics #Immunotherapy

📢 Exciting news! We’ve appointed experienced immunology drug development specialist Shane Olwill as Chief Development Officer! Shane will lead IND-enabling studies & clinical trials planning for our lead asset AT-108. See here for more bit.ly/4iQLtD1

🌟Asgard Therapeutics welcomes leading experts in drug development and cancer immunotherapy to the company. Dr Cristina Csimma joins our Board of Directors, while Prof Ignacio Melero and Prof Brian Brown join our Clinical and Scientific Advisory Board. Read more: bit.ly/4dH0wxc